ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) shares rose 2.6% during trading on Friday . The stock traded as high as $6.30 and last traded at $5.51. Approximately 52,836 shares changed hands during mid-day trading, a decline of 45% from the average daily volume of 96,746 shares. The stock had previously closed at $5.37.
ENDRA Life Sciences Stock Performance
The stock has a market cap of $2.96 million, a price-to-earnings ratio of -0.01 and a beta of 0.67. The stock’s 50-day simple moving average is $6.65 and its two-hundred day simple moving average is $2,914.54.
About ENDRA Life Sciences
ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
See Also
- Five stocks we like better than ENDRA Life Sciences
- What Investors Need to Know to Beat the Market
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- CarMax Gets in Gear: Is Now the Time to Buy?
- How to Use Stock Screeners to Find Stocks
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
